Obesity Accounts for Considerable Proportion of Polypharmacy Cases

Population-attributable fraction of polypharmacy due to BMI-defined obesity was 14.8 percent, corresponding to 3.3 million older adults
obesity
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on
Updated on
Loading content, please wait...
logo
www.healthday.com